xIPOmeter
ConcertAI
ConcertAI es líder en soluciones de IA para oncología, aprovechando los datos del mundo real para acelerar la investigación del cáncer y mejorar los resultados de los pacientes. Su plataforma ofrece análisis avanzados y perspectivas clínicas a empresas farmacéuticas, proveedores de atención sanitaria y organizaciones de investigación. La tecnología de ConcertAI está impulsando la innovación en la oncología de precisión y la atención al paciente.
Gráfico NewsHeat
- Semana
- Mes
- Año
- Noticias de prensa
- Noticias corporativas
Los datos del gráfico anterior se basan en datos derivados de nuestro modelo de cálculo XP patentado y pueden modificarse, ajustarse y actualizarse sin previo aviso.
Valoración de empresas
- Valoración
- Precio de las acciones
- Financiación acumulada
Los datos de los cuadros y gráficos se basan en datos de fuentes públicas y, aunque hacemos todo lo posible por recopilarlos, es posible que no coincidan con los datos reales del emisor.
*** - Para ver los datos, conéctese a su cuenta o cree una nueva.
Noticias relacionadas con ConcertAI66
ConcertAIConcertAI Appoints Timothy Albury as Chief Financial Officer
Leading Cancer Epidemiologist with Long Academic and Industry Career to Lead Regulatory and Registry Practice in Oncology and Hematology CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ – ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Sol...
ConcertAIhttps://www.concertai.com/news/appoints-timothy-albury-as-chief-financial-officerConcertAIConcertAI Appoints Timothy Albury as Chief Financial Officer
PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, today...
https://www.prnewswire.com/news-releases/concertai-appoints-timothy-albury-as-chief-financial-officer-302167714.htmlConcertAINick Jones Appointed SVP and GM Commercial Solutions
Leading Cancer Epidemiologist with Long Academic and Industry Career to Lead Regulatory and Registry Practice in Oncology and Hematology CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ – ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Sol...
ConcertAIhttps://www.concertai.com/news/nick-jones-appointed-svp-and-gm-commercial-solutionsConcertAI2024 ASCO Annual Meeting study demonstrates that AI models for predicting patient availability for clinical trials showed a 2 – 4x improvement over traditional approaches
Ryan Kennedy brings over 20 years’ experience leading technical innovation in the clinical research industry CAMBRIDGE, Mass., Jan. 24, 2024 /PRNewswire/ – ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data f...
ConcertAIhttps://www.concertai.com/news/2024-asco-annual-meeting-study-demonstrates-that-ai-models-for-predicting-patient-availability-for-clinical-trials-showed-a-2-4x-improvement-over-traditional-approachesConcertAIConcertAI: 2024 ASCO Annual Meeting study demonstrates that AI ...
PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) solutions for clinical research, announced the....
https://www.prnewswire.com/news-releases/concertai-2024-asco-annual-meeting-study-demonstrates-that-ai-models-for-predicting-patient-availability-for-clinical-trials-showed-a-2--4x-improvement-over-traditional-approaches-302162783.html
Ver más (61)Inversores2
Sixth Street
Declaration Partners